10X Genomics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 10X Genomics Inc 公司

10x Genomics, Inc. 是一家生命科学技术公司。该公司的综合解决方案包括用于分析生物系统的仪器、耗材和软件。其 Chromium 平台包括 Chromium X 系列、Chromium Connect 和传统 Chromium Controller 仪器、微流控芯片和相关耗材，可实现单个生物成分的通量分析。其 Visium 平台使研究人员能够以高分辨率了解组织内生物分析物的空间位置。其用于原位分析的 Xenium 平台旨在让科学家不仅能够在组织环境中定位和分类细胞。其产品包括 Chromium 单细胞基因表达、Chromium 单细胞基因表达 Flex、Chromium 单细胞免疫分析、Chromium 单细胞转座酶可及染色质 (ATAC) 检测、Chromium 单细胞多组 ATAC + 基因表达、Visium 空间基因表达等。

10X Genomics Inc简介



公司代码TXG

公司名称10X Genomics Inc

上市日期Sep 12, 2019

CEOMr. Serge Wilson Saxonov, Ph.D.

员工数量1306

证券类型Ordinary Share

年结日Sep 12

公司地址6230 Stoneridge Mall Road

城市PLEASANTON

上市交易所NASDAQ Global Select Consolidated

国家United States of America

邮编94588

电话19254017300

网址https://www.10xgenomics.com/

公司代码TXG

上市日期Sep 12, 2019

CEOMr. Serge Wilson Saxonov, Ph.D.

10X Genomics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.06M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

44.69K

-14.35%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

Dr. Shehnaaz Suliman, M.D.

Independent Director

28.62K

+115.82%

Mr. Adam S. Taich

Chief Financial Officer

--

Mr. Alan V. Mateo

Independent Director

--

Dr. Sarah A. Teichmann

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Serge Wilson Saxonov, Ph.D.

Chief Executive Officer, Co-Founder, Director

1.06M

-0.09%

Dr. John R. Stuelpnagel

Independent Chairman of the Board

369.61K

+4.34%

Whitaker (Eric S)

Chief Legal Officer

202.20K

+29.09%

Mr. Sridhar (Sri) Kosaraju

Independent Director

59.45K

+34.83%

Dr. Benjamin J. Hindson, Ph.D.

President, Co-Founder, Chief Scientific Officer, Director

44.69K

-14.35%

Ms. Kimberly J. (Kim) Popovits

Independent Director

28.62K

+115.82%

收入明细

单位: USD更新时间: 7 小时前

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Consumables

122.19M

70.66%

Products and services revenue

27.75M

16.05%

Instruments

14.50M

8.38%

Services

8.47M

4.90%

地区USD

名称

营收

占比

United States

103.49M

59.85%

Europe, the Middle East and Africa

34.73M

20.09%

China

23.17M

13.40%

Asia Pacific

8.85M

5.12%

Americas

2.67M

1.54%

业务

地区

业务USD

名称

营收

占比

Consumables

122.19M

70.66%

Products and services revenue

27.75M

16.05%

Instruments

14.50M

8.38%

Services

8.47M

4.90%

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

ARK Investment Management LLC

12.14%

The Vanguard Group, Inc.

10.85%

Fidelity Management & Research Company LLC

6.68%

BlackRock Institutional Trust Company, N.A.

6.63%

Sumitomo Mitsui Trust Bank, Limited

5.26%

其他

58.44%

持股股东

占比

ARK Investment Management LLC

12.14%

The Vanguard Group, Inc.

10.85%

Fidelity Management & Research Company LLC

6.68%

BlackRock Institutional Trust Company, N.A.

6.63%

Sumitomo Mitsui Trust Bank, Limited

5.26%

其他

58.44%

股东类型

持股股东

占比

Investment Advisor

53.51%

Investment Advisor/Hedge Fund

22.37%

Hedge Fund

14.10%

Bank and Trust

6.38%

Research Firm

4.97%

Venture Capital

2.31%

Individual Investor

1.85%

Pension Fund

0.63%

Family Office

0.51%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

662

119.53M

104.47%

-16.69M

2025Q2

669

120.42M

108.39%

-15.20M

2025Q1

687

115.67M

104.27%

-8.84M

2024Q4

689

107.08M

98.92%

-12.41M

2024Q3

682

106.90M

100.39%

-9.08M

2024Q2

691

105.36M

99.70%

-5.09M

2024Q1

762

106.36M

101.17%

-3.12M

2023Q4

817

100.80M

96.01%

-9.73M

2023Q3

835

96.86M

93.80%

-12.55M

2023Q2

857

94.98M

96.77%

-15.37M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

ARK Investment Management LLC

13.89M

12.14%

+1.05M

+8.15%

Jun 30, 2025

The Vanguard Group, Inc.

12.42M

10.85%

+1.32M

+11.92%

Jun 30, 2025

Fidelity Management & Research Company LLC

7.64M

6.68%

-930.78K

-10.85%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

7.58M

6.63%

+2.17M

+40.18%

Jun 30, 2025

Sumitomo Mitsui Trust Bank, Limited

6.02M

5.26%

+654.60K

+12.20%

Jun 30, 2025

AQR Capital Management, LLC

4.14M

3.62%

+2.93M

+241.28%

Jun 30, 2025

BofA Global Research (US)

2.91M

2.54%

+350.99K

+13.74%

Jun 30, 2025

Millennium Management LLC

2.88M

2.52%

-2.65M

-47.89%

Jun 30, 2025

Two Sigma Investments, LP

2.84M

2.48%

-329.64K

-10.40%

Jun 30, 2025

Geode Capital Management, L.L.C.

2.65M

2.32%

+773.20K

+41.18%

Jun 30, 2025

持股ETF



更新时间: 16 小时前

机构名称

占比

ARK Genomic Revolution ETF

4.36%

WisdomTree BioRevolution Fund

2.19%

Global X Genomics & Biotechnology ETF

1.7%

Janus Henderson Small Cap Growth Alpha ETF

1.61%

ARK Innovation ETF

1.38%

Harbor Long-Short Equity ETF

1.06%

Invesco NASDAQ Future Gen 200 ETF

0.59%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.51%

Principal U.S. Small-Cap ETF

0.22%

Vanguard US Quality Factor ETF

0.16%

ARK Genomic Revolution ETF

占比4.36%

WisdomTree BioRevolution Fund

占比2.19%

Global X Genomics & Biotechnology ETF

占比1.7%

Janus Henderson Small Cap Growth Alpha ETF

占比1.61%

ARK Innovation ETF

占比1.38%

Harbor Long-Short Equity ETF

占比1.06%

Invesco NASDAQ Future Gen 200 ETF

占比0.59%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比0.51%

Principal U.S. Small-Cap ETF

占比0.22%

Vanguard US Quality Factor ETF

占比0.16%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据